- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01945697
Validation of DNA Methylation Biomarkers for Oral Cancer Detection
December 21, 2017 updated by: National Taiwan University Hospital
The aim of this study is to evaluate the association between several methylated genes and oral cancers.
A prospective case control trial is designed with sample size estimated at least 160 cases.
It is expected to enroll at least 100 subjects with precancerous lesion or oral cancer, and ~60 subjects with normal oral mucosa.
This study is approved by the National Taiwan University Hospital Research Ethics Committee.
After signing the informed consent, all of the subjects will receive an intraoral examination and the oral epithelial cells will be collected.
If abnormal oral lesion is observed, it will be photographed, and the biopsy will be performed to confirm the diagnosis.
For methylated gene detections, the gDNA will be extracted from the collected cells and standardized assay will be performed.
Clinical sensitivity and specificity for these methylated genes will be evaluated.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
267
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Taipei, Taiwan, 100
- Department of Dentistry National Taiwan University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients come to the Department of Dentistry of National Taiwan University Hospital for oral health care or treatment.
Description
Inclusion Criteria:
- Subject with age over 20.
- Subject agrees to sign the informed consent form.
Exclusion Criteria:
- Subjects have history of head and neck cancer.
- Subjects have had received chemotherapy for cancers.
- Pregnant Woman
- Subjects whose has oral mucosal lichen planus.
- Subjects whose oral mucosal findings is abnormal, but the diagnosis is unknown.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
normal oral mucosa
|
oral precancerous lesion or oral cancer
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
DNA methylation labeled
Time Frame: 2 years
|
To validate the association between the methylation genes and the oral cancer
|
2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Shih-Jung Cheng, MD, Department of Dentistry National Taiwan University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2012
Primary Completion (Actual)
September 1, 2014
Study Completion (Actual)
September 1, 2014
Study Registration Dates
First Submitted
September 15, 2013
First Submitted That Met QC Criteria
September 15, 2013
First Posted (Estimate)
September 18, 2013
Study Record Updates
Last Update Posted (Actual)
December 26, 2017
Last Update Submitted That Met QC Criteria
December 21, 2017
Last Verified
September 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 201207019
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Oral Cancer
-
Royal Surrey County Hospital NHS Foundation TrustCompleted
-
Centre Francois BaclesseTerminatedCancer | Cognitive Function | Compliance | Oral TherapiesFrance
-
University of WashingtonBlaze Bioscience Inc.RecruitingStage III Lip and Oral Cavity Cancer AJCC v8 | Oral Cavity Squamous Cell Carcinoma | Stage I Lip and Oral Cavity Cancer AJCC v8 | Stage II Lip and Oral Cavity Cancer AJCC v8 | Stage IVA Lip and Oral Cavity Cancer AJCC v8United States
-
National Cancer Institute (NCI)CompletedLip and Oral Cavity Cancer | Oropharyngeal Cancer | Tongue Cancer | Oral LeukoplakiaUnited States
-
National Cancer Institute (NCI)CompletedLip and Oral Cavity Cancer | Oropharyngeal Cancer | Tongue Cancer | Stage 0 Lip and Oral Cavity Cancer | Stage 0 Oropharyngeal CancerUnited States
-
Dana-Farber Cancer InstituteCompletedBreast Cancer | Gastrointestinal Cancer | Oral Cancer Directed Therapy | Oral ChemotherapyUnited States
-
Ohio State University Comprehensive Cancer CenterCompletedTongue Cancer | Lip and Oral Cavity Squamous Cell Carcinoma | Oral Cavity Verrucous Carcinoma | Stage 0 Lip and Oral Cavity CancerUnited States
-
University of British ColumbiaRecruiting
-
Centre Francois BaclesseLigue contre le cancer, FranceCompletedManagement of Oral Care and Cancer in Palliative SituationFrance
-
Istituto Scientifico Romagnolo per lo Studio e...Kessler FoundationUnknownCancer | Oral Drug AdministrationItaly